In a significant move that could reshape the landscape of cardiovascular medicine for millions of Americans, a comprehensive bipartisan appropriations bill is advancing through Congress, carrying with it major implications for how patients access care and how the nation invests in medical research.
We're joined today by Ivan Kairatov, a biopharma expert whose work at the intersection of technology and research is pushing the boundaries of what’s possible in patient care. We'll be exploring a groundbreaking AI-powered wearable that translates silent throat movements into fluent speech for
Artificial intelligence has made remarkable strides in recognizing human emotions from facial expressions and tone of voice, but a groundbreaking new framework is now aiming for a far more ambitious goal: computationally modeling how emotions are formed in the first place. Researchers in Japan have
As a biopharma expert deeply embedded in the intersection of technology and research, Ivan Kairatov offers a pragmatic perspective on the integration of artificial intelligence into medicine. He navigates the hype surrounding large language models to focus on the rigorous clinical evaluation needed
Harnessing the immense chemical complexity of the natural world through the lens of artificial intelligence is fundamentally reshaping the landscape of modern medicine and biotechnology. This review explores the evolution of this approach, its key technological components, recent clinical
For families grappling with the hereditary specter of Huntington's disease, the certainty of a genetic diagnosis has always been shadowed by a profound and distressing uncertainty about when its devastating symptoms will begin. This devastating neurodegenerative disorder, caused by a known mutation
